Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19
(World News Science)

Press Release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY) Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19 The two companies will jointly investigate multiple candidates with the goal of advancing an efficacious and safe SARS-CoV-2 vaccine into clinical development PARIS and LEXINGTON, MASS. - March 27, 2020 - Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio (NASDAQ: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company, will collaborate to develop a novel mRNA vaccine for COVID-19. This collaboration leverages an existing agreement from 2018 between the two companies to develop mRNA vaccines for...